Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amoxicillin (1 trial)
bismuth (1 trial)
ceftazidime (fortaz) (1 trial)
clarithromycin (biaxin) (1 trial)
domperidone (1 trial)
esomeprazole (nexium) (1 trial)
glucose (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
sulbactam (unasyn) (1 trial)
vonoprazan (Voquezna) (1 trial)
capecitabine (xeloda) (2 trials)
cisplatin (platinol) (1 trial)
cytarabine (cytosar-u) (1 trial)
gemcitabine (gemzar) (1 trial)
idarubicin (idamycin) (1 trial)
sorafenib (nexavar) (1 trial)
toripalimab (LOQTORZ) (2 trials)
umbilical cord mesenchymal stem cells (1 trial)
doxorubicin (Doxil) (1 trial)
albuterol (proventil) (1 trial)
ipratropium (atrovent) (1 trial)
Carcinoma (Phase 2)
Fractures, Bone (Phase 2)
Lung Neoplasms (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Premature Birth (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Trials (10 total)
Trial APIs (21 total)